HLA typing in cancer
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
HLA-DR - Wikipedia
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis - ScienceDirect
HLA Gene May Predict if Cancer Immunotherapy Will Work - NCI
Gift of Life
HLA Matching
Differential expression of several surface markers on HLA-DR+ and... | Download Scientific Diagram
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
Simplified model of how human leukocyte antigen (HLA)-G mediates its... | Download Scientific Diagram
Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
Frontiers | Regulation of NK-Cell Function by HLA Class II
HLA typed cancer cells
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy | Molecular Medicine | Full Text
Human T cells recognize HLA-DP–bound peptides in two orientations | PNAS
HLA-typed cells and their role in immunotherapy - PromoCell
HLA LOH Monitoring — JETA Molecular
Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
Frontiers | Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
